Clinical Trial Update: Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating targeted BEACOPP variants in newly diagnosed advanced classical Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin Lymphoma | Phase 2 | Status: COMPLETED